Pharma International

What Pharma International does

Pharma International Inc. (株式会社ファーマインターナショナル) is a Tokyo-headquartered healthcare communication agency specializing in marketing communications for medical drugs and pharmaceutical companies, founded in June 1987. The firm serves 50+ pharmaceutical enterprise clients across Japan with a 120-person professional services team organized around cross-functional project pods (Account Executive, Medical Writer, Planner, Creative, supplemented by digital and event teams). Core deliverables span promotional print materials, digital content, mobile applications, video, websites, symposia, seminars, and events, producing 4,000+ materials annually across eight therapeutic areas including oncology, immunology/allergy, lifestyle diseases, psychiatry, gastroenterology, respiratory, urology, and ophthalmology.

Revenue is generated through project-based and retainer professional services engagements with pharmaceutical clients, sourced via direct sales led by dedicated account executives. The company distinguishes itself through a proprietary internal Regulation Meister certification system that standardizes regulatory compliance expertise across all staff, ISO 27001-certified information security management, and in-house regulation review services covering Japanese pharmaceutical advertising codes. Its portfolio includes the GI Cancer-Net oncology portal and the Clinical Newswire international medical conference reporting service operated via affiliated company MNC Systems. Group structure includes wholly-owned subsidiary Medsci Press (medical publishing) and Kikaku America International (Washington D.C., supporting global conference coordination), plus membership in The Bloc global alliance of independent pharmaceutical advertising agencies. Pricing is quote-based and not publicly disclosed, and no revenue figures or funding history are available, consistent with its private, founder/family-controlled status.

Name

Pharma International

Legal name

株式会社ファーマ国际机场

Website

https://pharma.co.jp

Company type

Private

Founded year

1987

Operating status

Operating

Headcount range

51–100 employees

Short description

Pharma International is a Tokyo-based healthcare communication agency serving 50+ Japanese pharmaceutical companies with marketing communications, regulatory review, digital content, and event production across multiple therapeutic areas.

Ownership category

akta.pro rank

Product category

Healthcare Marketing Communications

NAICS

Advertising, Public Relations, and Related Services (5418)

akta.pro primary industry

Healthcare/Pharma Creative Agencies (MPAAAAAJ)

Keywords

• Pharmaceutical advertising
• Healthcare marketing
• Medical communications
• Promotional materials production
• Regulatory review services

Headquarters

HQ city

Chuo

HQ country

Japan

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Healthcare marketing communications services: Professional agency fees for marketing communication services including print materials, digital content, applications, events, and regulatory review services. Revenue derived from project-based and retainer engagements with pharmaceutical company clients.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Pharma International is a healthcare communication agency that plans and produces marketing communications for pharmaceutical companies, including print promotional materials, digital content, applications, and events across multiple therapeutic areas. The firm also offers specialized regulation review services to ensure materials comply with Japanese pharmaceutical advertising codes, supported by an in-house Regulation Master certification program. Services are delivered as project-based and retainer engagements to 50+ pharmaceutical company clients, with bilingual staff supporting international medical conference coordination.

Product overview

Pharma International Inc. (株式会社ファーマインターナショナル) is a specialized healthcare communication agency serving over 50 pharmaceutical companies. The company operates as a single integrated agency with multiple specialized service lines: core marketing communication services (including print materials, digital content, applications, and events production), regulation review services (with certified Regulation Master specialists), and digital platforms (GI Cancer-Net portal and Clinical Newswire). The company also provides privacy mark and ISO 27001 information security management services. The portfolio spans therapeutic areas including oncology, immunology/allergy, lifestyle diseases, psychiatry, gastroenterology, respiratory, and urology, with global network capabilities through affiliated companies.

Differentiator

Problem solved

Functional benefit

Brands

• GI cancer-net: Portal website for comprehensive gastrointestinal cancer treatment information, created and operated by specialized oncology doctors
• Clinical Newswire

Products and services

• Healthcare Communication Services (ヘルスケアコミュニケーションサービス) Comprehensive marketing communication agency services for pharmaceutical companies, including promotional materials, digital content, applications, and event planning and production across multiple therapeutic areas such as oncology, immunology/allergy, lifestyle diseases, psychiatry, gastroenterology, respiratory, urology, and ophthalmology. Targets pharmaceutical manufacturer clients needing compliant promotional communications across the product lifecycle.
• Pharmaceutical Client Services (製薬企業向けサービス)

Quantifiable outcome

• Produces 4,000+ diverse materials per year across print, digital, and events
• +2 more outcomes

Named customers32 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Four partnerships are on record, tiered core.

• The BloccoreStrategic or Co-development PartnerThe Bloc is a global network of independent pharmaceutical advertising agencies. Pharma International is a member of this alliance network, enabling global collaboration and best practice sharing among independent pharmaceutical communications agencies worldwide.
• 株式会社医科学出版社 (Ika Kagaku Shuppansha / Medical Science Press)coreOthersWholly-owned subsidiary of Pharma International. Operates in the medical science publishing field, producing books and publications related to healthcare and pharmaceuticals.
• Kikaku America International (Washington D.C., USA)coreOthersUS-based subsidiary of Pharma International located in Washington D.C., supporting international operations and global conference coordination.
• 株式会社エムエヌシーシステムズ (MNCC Systems / MNC Systems)coreOthersRelated company that operates the Clinical Newswire portal (https://www.clinicalnewswire.com/), providing timely updates on international medical conferences. Affiliated with Pharma International through shared business interests.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• The Bloc: The Bloc is a global alliance of independent pharmaceutical creative agencies of which Pharma International is a member. Directly comparable as a network of independent pharma-focused creative shops serving similar Big Pharma clients with similar services.
• Ogilvy Health: Healthcare and pharma creative specialty of WPP/Ogilvy. A direct peer offering creative, medical communications, and digital services to pharma clients globally, including a Japan presence serving Japanese pharma companies.
• Saatchi & Saatchi Wellness: Publicis-owned pharma/health creative agency. Comparable in focus on healthcare professional and consumer communications for pharma clients, with overlapping service lines and award-recognized creative work.
• McCann Health: Global health-focused creative agency network under IPG/McCann. Directly competes for pharma client creative and communication budgets with the same full-service, regulatory-aware proposition Pharma International offers to Japanese pharma clients.
• Publicis Health: Publicis Groupe's health-focused creative and communications network. Direct competitor in pharma creative services, with global reach into Japan via Publicis Japan and similar client roster.
• IPG Health (FCB Health): IPG's dedicated health creative network including FCB Health. Direct competitor in pharma creative and medical communications, comparable in client roster of major pharma companies and global delivery model.

Emerging players

• Intouch Group: Digital-first pharma marketing agency. Comparable in serving pharma clients but with a narrower focus on digital and customer experience capabilities rather than full-service traditional pharma creative.
• Calcium (Calcium + Company): Independent healthcare creative agency with strong digital and content capabilities. Comparable in offering pharma creative services but with a stronger digital-first positioning relative to Pharma International's traditional agency model.

Broad incumbents

• Hakuhodo: Japan's second-largest advertising agency group with a dedicated healthcare division serving pharmaceutical clients. A broader incumbent that competes for the same pharma marketing budgets from a wider portfolio perspective.
• Dentsu: Japan's largest advertising agency with significant healthcare/pharma practice. A broad incumbent whose healthcare division overlaps with Pharma International's pharma client base and service scope.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/PharMaInternational
• Instagraminstagram.com/PharMaInternational

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharma International